SEC – ‘UPLOAD’ from 11/14/22 re: Orthofix Medical Inc. – ‘TEXT-EXTRACT’

On:  Monday, 11/14/22, at 6:30pm ET   ·   Delayed-Release:  Filing ¶  –  Release Delayed   ·   Accession #:  0-22-12361

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Comment or Other Letter from the SEC   —   Delayed-Release

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: LETTER      Comment or Other Letter from the SEC                 PDF     37K 
 2: TEXT-EXTRACT  Comment or Other Letter from the SEC - PDF's         1      5K 
                Text                                                             

‘TEXT-EXTRACT’   —   Comment or Other Letter from the SEC – PDF’s Text

United States securities and exchange commission logo                           

November 14, 2022             

Jon C. Serbousek                                                  
Chief Executive Officer                                           
Orthofix Medical Inc.                                             
3451 Plano Parkway                                                
Lewisville, Texas 75056                                           

                                                    Re: Orthofix Medical
Inc.                                                                            
                                                    Registration
Statement on Form S-4                                                           
                                                         Filed November 8,
2022                                                                            
                                                           File No. 333-268234

Dear Jon C. Serbousek:                                            

        This is to advise you that we have not reviewed and will not
review your registration                                                        
statement.                                                        

      Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you                                                     
      that the company and its management are responsible for the accuracy and
adequacy of their                                                               
     disclosures, notwithstanding any review, comments, action or absence of
action by the staff.                                                            

                                                   Please contact Abby
Adams at (202) 551-6902 with any questions.                                     

Sincerely,                    

 Division of Corporation Finance

       Office of Industrial Applications and

Services                      
  cc:                                              Joseph E. Gilligan,
Esq.                                                                            

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘UPLOAD’ Filing		Date		Other Filings
Filed on:		11/14/22		UPLOAD
		11/8/22		S-4,  S-8,  UPLOAD
				List all Filings